ReviewAnalytical science advances2025
Advancing Untargeted Metabolomics Through FT-ICR-MS: Challenges and Applications.
Review in Analytical science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advancing Untargeted Metabolomics Through FT-ICR-MS: Challenges and Applications.Analytical science advances · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolomics is the study of the complete set of small molecules involved in the biochemical processes within a biological system. It links directly to metabolism, capturing the biochemical pathways and processes in a state-specific manner and aiming to understand the dynamic interactions within these metabolites, including how they reflect the physiological and environmental conditions as well as cellular and physiological responses. Presently, Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS) is the highest performance mass spectrometry technology for untargeted metabolomic analysis, allowing the simultaneous detection of thousands of compounds in a single analysis. This analytical performance is due to its extreme mass resolution and exceptional mass accuracy, unmatched by any other type of mass spectrometer. This technology enables precise identification and differentiation of metabolites within complex biological samples, providing highly accurate molecular formulas, based on exact mass and fine isotopic distribution. This review focuses on new developments in FT-ICR-MS technology for metabolomic analysis, new methodologies and recent applications. It also addresses the current challenges and perspectives for the use of FT-ICR-MS in metabolomics.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.